Search

everythinglearnresearchcommunity

for

Search:↓

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Farudodstat may help prevent hair loss in alopecia areata by stopping immune attacks on hair follicles.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

The document concludes that a new biosensor can efficiently detect prostate cancer cells and that standardized referrals help find significant cancers effectively.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Keratin 19 forms less stable and shorter filaments than keratin 14, giving unique traits to certain skin cells.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Tofacitinib helped regrow hair in a woman with alopecia areata.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

Combining specific nanoparticles with immune therapy significantly improves cancer treatment.

New therapies and trials are needed for Merkel cell carcinoma, a tough skin cancer.

Merkel cell polyomavirus can infect and persist in skin cells, evading the immune system, but certain treatments can control it.

CD4+ skin cells may be precursors to basal cell carcinoma.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Early intervention with JAK inhibitors may prevent alopecia areata progression.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Higher levels of IL-1R1 and hsa-miR-19b-3p may help diagnose and predict alopecia areata severity.

Keratin 19 may help diagnose and treat certain types of permanent hair loss.

Oral tacrolimus helped a rheumatoid arthritis patient regrow hair lost due to alopecia areata.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

BTNL2 helps protect hair follicles from immune attacks.

RAR-gamma 1 is important for normal skin maintenance and differentiation.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.